HIV Scientific Papers
Clinical predictors of liver fibrosis presence and progression in HIV-associated NAFLD.
2020
Fourman LT, Stanley TL, Feldpausch M, et al.
Oral presentation #128 at: Conference on Retroviruses and Opportunistic Infections; March 8-11, 2020; Boston, Massachusetts, USA. Session O-10.
Clinical predictors of liver fibrosis presence and progression in HIV-associated NAFLD.
2020
Clin Infect Dis.
Fourman LT, Stanley TL, Zheng I, et al.
ciaa382.
Long-term efficacy, safety and durability of ibalizumab in expanded access study.
2019
HIV Medicine
Moyle G, Perno CF, Emu B, et al.
20 (suppl 9): 169. Proceedings of 17th (2019) European AIDS Conference
Long-term efficacy, safety and durability of ibalizumab in expanded access study.
2019
Moyle G, Perno CF, Emu B, et al.
Poster #PE13/16 presented at: 17th European AIDS Conference; November 6-9, 2019; Basel, Switzerland.
Ibalizumab efficacy and safety through 48 weeks of treatment: results of an expanded access protocol (TMB-311) [abstract].
2019
Open Forum Infect Dis.
Emu B, DeJesus E, Berhe M, et al.
6 (suppl 2):S303. Proceedings of IDWeek, 2019.